Emma Tinsley - CEO and co-founder of Weatherden

Prior to co-founding Weatherden, Emma was part of SV Health Investors, where she specialised in venture capital company creation, forming five biotech companies across immunology and oncology. Earlier in her career, she worked within the Life Sciences team at KPMG.

Tom Goodman and Ellen Dewhurst - Cooley LLP

Nadiya Ishnazarova and Christian Uhrich - M Ventures

We asked an investor and a law firm to join us for this conversation, as these two perspectives will illuminate the nuances founders must understand - across legal protections, economic rights, and governance control.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Florian Burgdorf - Global Head of Procurement Academy 4.0 and Negotiation Trainings at Boston Consulting Group

Florian holds a PhD in Electrical Engineering and is a leading member of BCG's Operations and Industrial Goods practice areas, with a focus on procurement and R&D transformations, both digital and conventional.

Florian Burgdorf - Global Head of Procurement Academy 4.0 and Negotiation Trainings at Boston Consulting Group

Florian holds a PhD in Electrical Engineering and is a leading member of BCG's Operations and Industrial Goods practice areas, with a focus on procurement and R&D transformations, both digital and conventional.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jill McCullough - Personal Impact Coach

With over 30 years of experience coaching C-suite leaders from global organizations like KPMG, Mercedes, EY, and British Airways, Jill McCullough specializes in helping leaders refine their communication skills to project authority and inspire trust.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Josua Jordi - Co-Founder of EraCal Therapeutics

Josua co-founded EraCal Therapeutics in 2018 as a spin-off from the University of Zurich and Harvard University, with a mission to develop first-in-class treatments for obesity and metabolic disorders.

Vanessa King - Former CEO Tenpoint Therapeutics

Vanessa is a serial biotech CEO and Board member with global breadth. She brings a track record of significant financings, strategic partnerships, and of building exceptional organizations.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Cheryl Strauss Einhorn - Founder and CEO of Decisive

Cheryl is a long time educator, teaching at Columbia University and at Cornell University’s SC Johnson School of Business and Cornell Tech. She has also authored three books.

Cheryl Strauss Einhorn - Founder and CEO of Decisive

Cheryl is a long time educator, teaching at Columbia University and at Cornell University’s SC Johnson School of Business and Cornell Tech. She has also authored three books.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Cheryl Strauss Einhorn - Founder and CEO of Decisive

Cheryl is a long time educator, teaching at Columbia University and at Cornell University’s SC Johnson School of Business and Cornell Tech. She has also authored three books.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Koenraad Wiedhaup - Founder and CEO at Leyden Labs

Koenraad has a background in science, studying Life Sciences and Biotechnology at the Universities of Leiden and Delft and holds an MBA from Columbia Business School in New York.

Barnaby Balmforth - CEO and Co-Founder of BioFidelity

Barnaby’s strategic approach to team building on both sides of the Atlantic - emphasizing the recruitment of top talent, fostering an agile and innovative culture, and aligning the team with BioFidelity’s global mission - has been critical to the company’s rapid growth and international success.

Tom Goodman - Partner at Cooley

Mark Jones - Associate at Cooley

Simon Burr - Senior Associate at Novo Ventures Holding

Campbell Stewart - VP at Novo Ventures Holding

Space is limited and you must RSVP!

Sean Kendall - Partner at ARCH

A chemical engineer and synthetic biologist by training, Mr. Kendall was an early employee with LS9, Inc. (acquired by Genomatica), where he developed an automated experimentation and analysis platform for their synthetic biology platform.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jan Lichtenberg - Co-founder and CEO at InSphero

Jan is an engineer and laboratory automation expert with 20 years of experience in the life sciences. Jan earned his PhD in Microtechnology and Microfluidics at the University of Neuchâtel. He is a former Head of R&D and Product Management in the medical-device company Hocoma AG and Uwatec AG.

Marina Udier - CEO at Nouscom

In our new Female Founder Exchange Series, we will be asking seasoned life science CEOs to name the three biggest challenges (personal and/or professional) that they have encountered or are encountering by virtue of being a female leader and share what they did or are doing to overcome them.

François Candelon & Leonid Zhukov - BCG Henderson Institute

François Candelon is currently a Partner at Seven2, a French private equity firm. Previously, he served as the Global Director of the BCG Henderson Institute (2019-2024).

Leonid Zhukovis the Director of the BCG Global AI Institute, where he plays a pivotal role in exploring how artificial intelligence, particularly generative AI (GenAI), can transform industries.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Billy Boyle - CEO at Owlstone Medical Ltd

Billy is an engineering graduate from the University of Cambridge. He is one of the original co-founders of Owlstone Inc,.

Cheryl Strauss Einhorn - Founder of Decisive

Cheryl is an author and long time educator, having taught at Columbia Business School for over a decade and currently teaching at Cornell University’s SC Johnson School of Business and Cornell Tech.